Yu B, Chen HH, Hu XF, Mai RZ, He HY. Comparison of laboratory parameters, clinical symptoms and clinical outcomes of COVID-19 and influenza in pediatric patients: A systematic review and meta-analysis. World J Clin Cases 2022; 10(29): 10516-10528 [PMID: 36312478 DOI: 10.12998/wjcc.v10.i29.10516]
Corresponding Author of This Article
Bang Yu, PhD, Research Scientist, Emergency and Critical Care Center, Beijing Jingdu Children’s Hospital, No. 308 Huilongguan East Main Street, Changping District, Beijing 102200, China. flashmeteor@yeah.net
Research Domain of This Article
Infectious Diseases
Article-Type of This Article
Systematic Reviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Oct 16, 2022; 10(29): 10516-10528 Published online Oct 16, 2022. doi: 10.12998/wjcc.v10.i29.10516
Comparison of laboratory parameters, clinical symptoms and clinical outcomes of COVID-19 and influenza in pediatric patients: A systematic review and meta-analysis
Bang Yu, Hai-Hua Chen, Xiao-Fei Hu, Rui-Zhi Mai, Hai-Yan He
Bang Yu, Hai-Hua Chen, Xiao-Fei Hu, Rui-Zhi Mai, Hai-Yan He, Emergency and Critical Care Center, Beijing Jingdu Children’s Hospital, Beijing 102200, China
Author contributions: Yu B and Chen HH conceived and designed the study; Chen HH, Hu XF, Mai RZ and He HY collected the data and performed the analysis; Yu B was involved in the writing of the manuscript and is responsible for the integrity of the study; All authors have read and approved the final manuscript.
Conflict-of-interest statement: The authors declare that they have no competing interests.
PRISMA 2009 Checklist statement: The review was reported according to the PRISMA statement 2020.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Bang Yu, PhD, Research Scientist, Emergency and Critical Care Center, Beijing Jingdu Children’s Hospital, No. 308 Huilongguan East Main Street, Changping District, Beijing 102200, China. flashmeteor@yeah.net
Received: May 16, 2022 Peer-review started: May 16, 2022 First decision: July 13, 2022 Revised: July 26, 2022 Accepted: August 30, 2022 Article in press: August 30, 2022 Published online: October 16, 2022
Core Tip
Core Tip: Developing new strategies for prevention, early diagnosis and adequate management of pediatric patients infected with coronavirus disease 2019 (COVID-19) or influenza is crucial. It is still not clear which of these two viruses is more severe in pediatric patients and requires intensive interventions. In addition, co-circulation of influenza and COVID-19 present certain diagnostic and therapeutic difficulties, given the similarities in the clinical features, and may lead to adverse treatment outcomes. Our review is the first attempt to compare the various clinical features, laboratory parameters and outcomes between COVID-19 and influenza pediatric patients. However, longitudinal evidence is required to identify reliable effect sizes and to make evidence-based recommendations for developing interventions in the hospital setting.
